
Healthcare / Pharmaceuticals · NSE
Anondita Medicare Limited, founded in March 2024, is a condom manufacturer best known for its flagship brand “COBRA,” producing around 562 million flavored male condoms annually. Its manufacturing facility is located in Noida, Uttar Pradesh, and the company exports to Southeast Asia, Africa, and the Middle East. Partnering with global health organizations, NGOs, and governments, Anondita supports family planning and public health initiatives. With a strong distribution network, it ensures timely delivery through wholesalers, retailers, e-commerce platforms, and government health programs. As of July 31, 2025, the company employed 280 people.
Price Band
₹137 – ₹145
Issue Size
₹69.50 Cr
Lot Size
1000 shares
GMP
+61.4%
Est. Listing
₹234
at current GMP
Subscribed
301.09x
overall
Open
22 Aug 2025
Close
26 Aug 2025
Allotment
28 Aug 2025
Refund
29 Aug 2025
Demat Credit
30 Aug 2025
Listing
1 Sep 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹145
Band: ₹137 – ₹145
Estimated Listing Price
₹234
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,45,000
Estimated Profit / Lot
₹89,000
1000 × ₹89
Grey Market Premium trend
—
▼ 28 today
Updated 11 months ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 19 Aug 2025 | — | 0.0% | ₹145 |
| 20 Aug 2025 | +₹28 | 19.3% | ₹173 |
| 21 Aug 2025 | +₹47 | 32.4% | ₹192 |
| 22 Aug 2025 | +₹65 | 44.8% | ₹210 |
| 25 Aug 2025 | +₹70 | 48.3% | ₹215 |
| 26 Aug 2025 | +₹80 | 55.2% | ₹225 |
| 28 Aug 2025 | +₹86 | 59.3% | ₹231 |
| 29 Aug 2025 | +₹80 | 55.2% | ₹225 |
| 30 Aug 2025 | +₹85 | 58.6% | ₹230 |
| 31 Aug 2025 | +₹87 | 60.0% | ₹232 |
| 1 Sep 2025 | +₹89 | 61.4% | ₹234 |
| 5 Nov 2025 | +₹89 | 61.4% | ₹234 |
| 21 Nov 2025 | +₹89 | 61.4% | ₹234 |
GMP is unofficial market data. Not a guarantee of listing performance.
Anondita Medicare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹69.5 Crores. The shares are offered at a price band of ₹137 to ₹145 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-08-26, the basis of allotment is scheduled to be finalized on 2025-08-28. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Maashitla Securities Private Limited) or the BSE allotment checking window.
The latest grey market premium for Anondita Medicare Limited IPO is ₹89, which indicates an expected listing price of ₹234.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.